203 related articles for article (PubMed ID: 11064811)
1. Cell cycle-dependent AgNOR analysis in invasive breast cancer.
Krüger S; Stahlhut M; Müller H
Anal Quant Cytol Histol; 2000 Oct; 22(5):358-63. PubMed ID: 11064811
[TBL] [Abstract][Full Text] [Related]
2. Proliferation assessment in breast cancer: a double-staining technique for AgNOR quantification in MIB-1 positive cells especially adapted for image cytometry.
Lorenzato M; Abboud P; Lechki C; Browarnyj F; O'Donohue MF; Ploton D; Adnet JJ
Micron; 2000 Apr; 31(2):151-9. PubMed ID: 10588061
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of double staining of MIB-1 and AgNORs in primary breast carcinoma.
Kidogawa H; Nanashima A; Yano H; Matsumoto M; Yasutake T; Nagayasu T
Anticancer Res; 2005; 25(6B):3957-62. PubMed ID: 16309183
[TBL] [Abstract][Full Text] [Related]
4. Improvement of breast cancer prognostication using cell kinetic-based silver-stainable nucleolar organizer region quantification of the MIB-1 positive tumor cell compartment.
Biesterfeld S; Farokhzad F; Klüppel D; Schneider S; Hufnagl P
Virchows Arch; 2001 May; 438(5):478-84. PubMed ID: 11407476
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
[TBL] [Abstract][Full Text] [Related]
6. Nucleolar organizer regions in hepatocellular carcinoma related to the cell cycle, cell proliferation and histologic grade.
Nagao T; Ishida Y; Yamazaki K; Kondo Y
Pathol Res Pract; 1995 Oct; 191(10):967-72. PubMed ID: 8838363
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: correlation to tumor stage and long-term survival.
Ofner D; Bier B; Heinrichs S; Berghorn M; Dünser M; Hagemann HA; Langer D; Böcker W; Schmid KW
Breast Cancer Res Treat; 1996; 39(2):165-76. PubMed ID: 8872325
[TBL] [Abstract][Full Text] [Related]
8. Proliferative activity is a significant prognostic factor in male breast carcinoma.
Pich A; Margaria E; Chiusa L
Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
[TBL] [Abstract][Full Text] [Related]
9. Correlation between silver-stained nucleolar organizer region area and cell cycle time.
Canet V; Montmasson MP; Usson Y; Giroud F; Brugal G
Cytometry; 2001 Feb; 43(2):110-6. PubMed ID: 11169575
[TBL] [Abstract][Full Text] [Related]
10. AgNOR quantification with special reference to staining patterns.
Rüschoff J; Fauser G; Knüchel R; Hofstädter F
Zentralbl Pathol; 1994 Mar; 140(1):23-30. PubMed ID: 7515669
[TBL] [Abstract][Full Text] [Related]
11. Standardized AgNOR analysis of the invasive tumour front in oral squamous cell carcinomas.
Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
J Pathol; 1997 Aug; 182(4):450-6. PubMed ID: 9306967
[TBL] [Abstract][Full Text] [Related]
12. Correlation of two AgNOR counts with Ki-67 labeling index: a study in fine-needle aspirates of lymphoproliferative disorders and breast carcinoma.
Mourad WA; Sneige N; Katz RL; Ordóñez NG
Diagn Cytopathol; 1994; 10(2):113-9. PubMed ID: 8187588
[TBL] [Abstract][Full Text] [Related]
13. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of AgNORs in breast cancer].
Aubele M; Auer G; Jütting U
Zentralbl Pathol; 1994 Mar; 140(1):55-60. PubMed ID: 7515674
[TBL] [Abstract][Full Text] [Related]
15. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
16. Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool.
Giuffrè G; Mormandi F; Barresi V; Bordi C; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(1):45-50. PubMed ID: 16584984
[TBL] [Abstract][Full Text] [Related]
17. [AgNORs as an alternative to Ki67on paraffin-embedded material in breast carcinoma].
Oddi G; Visca P; Parisi AM
Pathologica; 1992; 84(1094):75-8. PubMed ID: 1300535
[No Abstract] [Full Text] [Related]
18. A multilabeling technique for simultaneous demonstration and quantitation of Ki-67 and nucleolar organizer regions (AgNORs) in paraffin-embedded tissue.
Munakata S; Hendricks JB
J Histochem Cytochem; 1994 Jun; 42(6):789-3. PubMed ID: 7514625
[TBL] [Abstract][Full Text] [Related]
19. The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence.
Kunishio K; Ohmoto T; Matsuhisa T; Maeshiro T; Furuta T; Matsumoto K
Cancer; 1994 Apr; 73(8):2200-5. PubMed ID: 8156526
[TBL] [Abstract][Full Text] [Related]
20. AgNORs in breast tumours.
Ceccarelli C; Trerè D; Santini D; Taffurelli M; Chieco P; Derenzini M
Micron; 2000 Apr; 31(2):143-9. PubMed ID: 10588060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
